Seladelpar lysine dihydrate MBX-8052

 Seladelpar lysine dihydrate  MBX-8052

一、 Product Overview

Seladelpar lysine dihydrate is a small molecule drug developed by Cymabay Therapeutics Inc and is a PPARδ agonist. This drug was approved by the FDA on August 14, 2024, for the treatment of sclerosing cholangitis.

二、Main products

Description	Structural Formula	CAS No.	Category
Seladelpar lysine dihydrate		928821-40-3	API
ethyl   2-(4-mercapto-2-methylphenoxy)acetate		343322-82-7	intermediates
(R)-2-((4-(trifluoromethyl)phenoxy)methyl)oxirane		256372-58-4	intermediates

Note: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and its liability is at buyer's risk.